Research Article Indicators of Quality of Clinical Care for Type 2 Diabetes Patients in Primary Health Care Centers in Qatar: A Retrospective Analysis Saleh Attal , 1 Mohamed H. Mahmoud, 1 Muna Taher Aseel, 1 Ady Candra, 1 Paul Amuna, 2 Mohamed Elnagmi, 1 Mostafa Abdallah, 1 Nahed Ismail, 1 Ahmed Abdelrazek, 1 Dia Albaw, 1 Abdulsalam Albashir, 1 and Hisham Elmahdi 1 1 Family Medicine Residency Program, Primary Health Care Corporation, West Bay Training Center, Doha, Qatar 2 Research Department, Primary Health Care Corporation, Doha, Qatar CorrespondenceshouldbeaddressedtoSalehAttal;alatalsaleh@yahoo.com Received 11 June 2019; Revised 4 September 2019; Accepted 20 November 2019; Published 5 December 2019 AcademicEditor:AlbertoFerlin Copyright©2019SalehAttaletal.isisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background.Despitethehighprevalenceoftype2diabetesmellitusinGulfcountries,standardsofdiabetescareattheprimary carelevelhavenotbeenwidelystudied. Aim.TocomparetheresultsofdiabetesclinicalindicatorsfromtheAmericanDiabetes Association(ADA)2017guidelinestothereferencebenchmarksintheBehavioralRiskFactorSurveillanceSystem. Materials and Methods.Across-sectionalanalysisofelectronicmedicalrecordsin643randomlyselectedadultpatientswithtype2diabeteswas undertaken. A checklist enabled the collection of sociodemographic, clinical, biochemical, and quality measurement data. Data wereanalyzedusingStata9.0.echi-squaredtestwasusedtocomparetwoormoreproportions. Results.erewere643patients (male � 60.3%; female � 39.7%), and the majority (71.7%) aged between 40 and 64 years. Common comorbidities were dysli- pidemia(72.3%),hypertension(70%),obesity(50.1%),andpreobesity(overweight)(37.9%).Over15%weresmokers.emost commonlyprescribeddiabetesmedicationsweremetformin(89.9%),dipeptidylpeptidase-4inhibitors(61.1%),andsulfonylureas (49.3%).Only35.5%(p < 0.0001)ofpatientsmetthereferenceglycatedhemoglobin(HbA1c)cutofflevelof7.0%.ereference level for blood pressure control was met by 70.2% (p < 0.0001) and for low-density lipoprotein cholesterol, 73.8% (p < 0.0001). Albuminuria was present in 39.2%, and very low vitamin D level (<20ng/ml) in 39.1%. Most patients had annual foot (89.6%, p < 0.0001)andeye(72.3%, p < 0.0001)examinations.Only39.9%hadreferralsfordietarycounseling,andtherewerelowerrates ofreferralsanduptakeforpneumococcal,influenza,andhepatitisBvaccines.Most(76.2%)didnothavescreeningfordepression. Conclusion. e majority of the results met the ADA standards, while glycemic control, dietary counseling, and screening for depression were poor in comparison to the standards. Continuing education for clinicians, patient education for self-man- agement, and targeted weight management are recommended. 1. Introduction Diabetes mellitus currently presents one of the most signif- icant burdens on public health. It is a chronic disease re- quiringcomprehensivemedicalcarecombinedwithdifferent risk-reduction strategies, not limited to glycemic control [1]. In 2015, over 415 million adults (aged 20–79 years) had di- abetes, consuming 12% of global health expenditure; their number is predicted to reach 642 million by 2040 [2]. In 2012, diabetes directly contributed to 1.5 million deaths globally, and uncontrolled blood glucose caused another 2.2 million deaths indirectly, through elevated cardiovascular risks and other diseases [3]. In Qatar, the prevalenceofdiabetesamongQatariadultswasestimatedat 16.7% in 2012, higher in women, and peaked in the age group 40–49 years (31.2%) [4]. Prevalence is expected to reach 24% and to consume 32% of total health expenditure by 2050 [5]. Hindawi International Journal of Endocrinology Volume 2019, Article ID 3519093, 9 pages https://doi.org/10.1155/2019/3519093